Global Full-Service Clinical Research Organization (CRO) Market Research Report 2023
Global Full-Service Clinical Research Organization (CRO) Market Overview:
Global Full-Service Clinical Research Organization (CRO) Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Full-Service Clinical Research Organization (CRO) involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Full-Service Clinical Research Organization (CRO) Market
The Full-Service Clinical Research Organization (CRO) Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Full-Service Clinical Research Organization (CRO) Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Full-Service Clinical Research Organization (CRO) Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Full-Service Clinical Research Organization (CRO) Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Full-Service Clinical Research Organization (CRO) market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Full-Service Clinical Research Organization (CRO) Market Segmentation
Global Full-Service Clinical Research Organization (CRO) Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Full-Service Clinical Research Organization (CRO) market has been segmented into:
Clinical CRO
Preclinical CRO
By Application, Full-Service Clinical Research Organization (CRO) market has been segmented into:
Small Medium Enterprise
Large Enterprise
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Full-Service Clinical Research Organization (CRO) market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Full-Service Clinical Research Organization (CRO) market.
Top Key Players Covered in Full-Service Clinical Research Organization (CRO) market are:
Syneos Health
Parexel
Premier Research
Courante Oncology
CMIC
PROMETRIKA
ICON
Wuxi Apptec
IQVIA
PRA
Labcorp
Medpace
Worldwide Clinical Trials
PPD
EPS International
Objective to buy this Report:
1. Full-Service Clinical Research Organization (CRO) analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Full-Service Clinical Research Organization (CRO) market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Global Full-Service Clinical Research Organization (CRO) Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Full-Service Clinical Research Organization (CRO) involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Full-Service Clinical Research Organization (CRO) Market
The Full-Service Clinical Research Organization (CRO) Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Full-Service Clinical Research Organization (CRO) Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Full-Service Clinical Research Organization (CRO) Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Full-Service Clinical Research Organization (CRO) Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Full-Service Clinical Research Organization (CRO) market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Full-Service Clinical Research Organization (CRO) Market Segmentation
Global Full-Service Clinical Research Organization (CRO) Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Full-Service Clinical Research Organization (CRO) market has been segmented into:
Clinical CRO
Preclinical CRO
By Application, Full-Service Clinical Research Organization (CRO) market has been segmented into:
Small Medium Enterprise
Large Enterprise
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Full-Service Clinical Research Organization (CRO) market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Full-Service Clinical Research Organization (CRO) market.
Top Key Players Covered in Full-Service Clinical Research Organization (CRO) market are:
Syneos Health
Parexel
Premier Research
Courante Oncology
CMIC
PROMETRIKA
ICON
Wuxi Apptec
IQVIA
PRA
Labcorp
Medpace
Worldwide Clinical Trials
PPD
EPS International
Objective to buy this Report:
1. Full-Service Clinical Research Organization (CRO) analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Full-Service Clinical Research Organization (CRO) market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
CHAPTER 1: INTRODUCTION
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:GROWTH OPPORTUNITIES BY SEGMENT
3.1 By Type
3.2 By Application
CHAPTER 4: MARKET LANDSCAPE
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
CHAPTER 5: FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET BY TYPE
5.1 Full-Service Clinical Research Organization (CRO) Market Overview Snapshot and Growth Engine
5.2 Full-Service Clinical Research Organization (CRO) Market Overview
5.3 Clinical CRO
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Clinical CRO: Geographic Segmentation
5.4 Preclinical CRO
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Preclinical CRO: Geographic Segmentation
CHAPTER 6: FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET BY APPLICATION
6.1 Full-Service Clinical Research Organization (CRO) Market Overview Snapshot and Growth Engine
6.2 Full-Service Clinical Research Organization (CRO) Market Overview
6.3 Small Medium Enterprise
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2028F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Small Medium Enterprise: Geographic Segmentation
6.4 Large Enterprise
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2028F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Large Enterprise: Geographic Segmentation
CHAPTER 7: COMPANY PROFILES AND COMPETITIVE ANALYSIS
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Full-Service Clinical Research Organization (CRO) Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Full-Service Clinical Research Organization (CRO) Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Full-Service Clinical Research Organization (CRO) Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 SYNEOS HEALTH
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 PAREXEL
7.4 PREMIER RESEARCH
7.5 COURANTE ONCOLOGY
7.6 CMIC
7.7 PROMETRIKA
7.8 ICON
7.9 WUXI APPTEC
7.10 IQVIA
7.11 PRA
7.12 LABCORP
7.13 MEDPACE
7.14 WORLDWIDE CLINICAL TRIALS
7.15 PPD
7.16 EPS INTERNATIONAL
CHAPTER 8: GLOBAL FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Clinical CRO
8.2.2 Preclinical CRO
8.3 Historic and Forecasted Market Size By Application
8.3.1 Small Medium Enterprise
8.3.2 Large Enterprise
CHAPTER 9: NORTH AMERICA FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Clinical CRO
9.4.2 Preclinical CRO
9.5 Historic and Forecasted Market Size By Application
9.5.1 Small Medium Enterprise
9.5.2 Large Enterprise
9.6 Historic and Forecast Market Size by Country
9.6.1 U.S.
9.6.2 Canada
9.6.3 Mexico
CHAPTER 10: EUROPE FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Clinical CRO
10.4.2 Preclinical CRO
10.5 Historic and Forecasted Market Size By Application
10.5.1 Small Medium Enterprise
10.5.2 Large Enterprise
10.6 Historic and Forecast Market Size by Country
10.6.1 Germany
10.6.2 U.K.
10.6.3 France
10.6.4 Italy
10.6.5 Russia
10.6.6 Spain
10.6.7 Rest of Europe
CHAPTER 11: ASIA-PACIFIC FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Clinical CRO
11.4.2 Preclinical CRO
11.5 Historic and Forecasted Market Size By Application
11.5.1 Small Medium Enterprise
11.5.2 Large Enterprise
11.6 Historic and Forecast Market Size by Country
11.6.1 China
11.6.2 India
11.6.3 Japan
11.6.4 Singapore
11.6.5 Australia
11.6.6 New Zealand
11.6.7 Rest of APAC
CHAPTER 12: MIDDLE EAST & AFRICA FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Clinical CRO
12.4.2 Preclinical CRO
12.5 Historic and Forecasted Market Size By Application
12.5.1 Small Medium Enterprise
12.5.2 Large Enterprise
12.6 Historic and Forecast Market Size by Country
12.6.1 Turkey
12.6.2 Saudi Arabia
12.6.3 Iran
12.6.4 UAE
12.6.5 Africa
12.6.6 Rest of MEA
CHAPTER 13: SOUTH AMERICA FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Clinical CRO
13.4.2 Preclinical CRO
13.5 Historic and Forecasted Market Size By Application
13.5.1 Small Medium Enterprise
13.5.2 Large Enterprise
13.6 Historic and Forecast Market Size by Country
13.6.1 Brazil
13.6.2 Argentina
13.6.3 Rest of SA
CHAPTER 14 INVESTMENT ANALYSIS
CHAPTER 15 ANALYST VIEWPOINT AND CONCLUSION
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:GROWTH OPPORTUNITIES BY SEGMENT
3.1 By Type
3.2 By Application
CHAPTER 4: MARKET LANDSCAPE
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
CHAPTER 5: FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET BY TYPE
5.1 Full-Service Clinical Research Organization (CRO) Market Overview Snapshot and Growth Engine
5.2 Full-Service Clinical Research Organization (CRO) Market Overview
5.3 Clinical CRO
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Clinical CRO: Geographic Segmentation
5.4 Preclinical CRO
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Preclinical CRO: Geographic Segmentation
CHAPTER 6: FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET BY APPLICATION
6.1 Full-Service Clinical Research Organization (CRO) Market Overview Snapshot and Growth Engine
6.2 Full-Service Clinical Research Organization (CRO) Market Overview
6.3 Small Medium Enterprise
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2028F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Small Medium Enterprise: Geographic Segmentation
6.4 Large Enterprise
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2028F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Large Enterprise: Geographic Segmentation
CHAPTER 7: COMPANY PROFILES AND COMPETITIVE ANALYSIS
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Full-Service Clinical Research Organization (CRO) Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Full-Service Clinical Research Organization (CRO) Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Full-Service Clinical Research Organization (CRO) Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 SYNEOS HEALTH
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 PAREXEL
7.4 PREMIER RESEARCH
7.5 COURANTE ONCOLOGY
7.6 CMIC
7.7 PROMETRIKA
7.8 ICON
7.9 WUXI APPTEC
7.10 IQVIA
7.11 PRA
7.12 LABCORP
7.13 MEDPACE
7.14 WORLDWIDE CLINICAL TRIALS
7.15 PPD
7.16 EPS INTERNATIONAL
CHAPTER 8: GLOBAL FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Clinical CRO
8.2.2 Preclinical CRO
8.3 Historic and Forecasted Market Size By Application
8.3.1 Small Medium Enterprise
8.3.2 Large Enterprise
CHAPTER 9: NORTH AMERICA FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Clinical CRO
9.4.2 Preclinical CRO
9.5 Historic and Forecasted Market Size By Application
9.5.1 Small Medium Enterprise
9.5.2 Large Enterprise
9.6 Historic and Forecast Market Size by Country
9.6.1 U.S.
9.6.2 Canada
9.6.3 Mexico
CHAPTER 10: EUROPE FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Clinical CRO
10.4.2 Preclinical CRO
10.5 Historic and Forecasted Market Size By Application
10.5.1 Small Medium Enterprise
10.5.2 Large Enterprise
10.6 Historic and Forecast Market Size by Country
10.6.1 Germany
10.6.2 U.K.
10.6.3 France
10.6.4 Italy
10.6.5 Russia
10.6.6 Spain
10.6.7 Rest of Europe
CHAPTER 11: ASIA-PACIFIC FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Clinical CRO
11.4.2 Preclinical CRO
11.5 Historic and Forecasted Market Size By Application
11.5.1 Small Medium Enterprise
11.5.2 Large Enterprise
11.6 Historic and Forecast Market Size by Country
11.6.1 China
11.6.2 India
11.6.3 Japan
11.6.4 Singapore
11.6.5 Australia
11.6.6 New Zealand
11.6.7 Rest of APAC
CHAPTER 12: MIDDLE EAST & AFRICA FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Clinical CRO
12.4.2 Preclinical CRO
12.5 Historic and Forecasted Market Size By Application
12.5.1 Small Medium Enterprise
12.5.2 Large Enterprise
12.6 Historic and Forecast Market Size by Country
12.6.1 Turkey
12.6.2 Saudi Arabia
12.6.3 Iran
12.6.4 UAE
12.6.5 Africa
12.6.6 Rest of MEA
CHAPTER 13: SOUTH AMERICA FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Clinical CRO
13.4.2 Preclinical CRO
13.5 Historic and Forecasted Market Size By Application
13.5.1 Small Medium Enterprise
13.5.2 Large Enterprise
13.6 Historic and Forecast Market Size by Country
13.6.1 Brazil
13.6.2 Argentina
13.6.3 Rest of SA
CHAPTER 14 INVESTMENT ANALYSIS
CHAPTER 15 ANALYST VIEWPOINT AND CONCLUSION
LIST OF TABLES
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET COMPETITIVE RIVALRY
TABLE 005. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET THREAT OF NEW ENTRANTS
TABLE 006. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET THREAT OF SUBSTITUTES
TABLE 007. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET BY TYPE
TABLE 008. CLINICAL CRO MARKET OVERVIEW (2016-2028)
TABLE 009. PRECLINICAL CRO MARKET OVERVIEW (2016-2028)
TABLE 010. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET BY APPLICATION
TABLE 011. SMALL MEDIUM ENTERPRISE MARKET OVERVIEW (2016-2028)
TABLE 012. LARGE ENTERPRISE MARKET OVERVIEW (2016-2028)
TABLE 013. NORTH AMERICA FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY TYPE (2016-2028)
TABLE 014. NORTH AMERICA FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY APPLICATION (2016-2028)
TABLE 015. N FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY COUNTRY (2016-2028)
TABLE 016. EUROPE FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY TYPE (2016-2028)
TABLE 017. EUROPE FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY APPLICATION (2016-2028)
TABLE 018. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY COUNTRY (2016-2028)
TABLE 019. ASIA PACIFIC FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY TYPE (2016-2028)
TABLE 020. ASIA PACIFIC FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY APPLICATION (2016-2028)
TABLE 021. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY COUNTRY (2016-2028)
TABLE 022. MIDDLE EAST & AFRICA FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY TYPE (2016-2028)
TABLE 023. MIDDLE EAST & AFRICA FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY APPLICATION (2016-2028)
TABLE 024. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY COUNTRY (2016-2028)
TABLE 025. SOUTH AMERICA FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY TYPE (2016-2028)
TABLE 026. SOUTH AMERICA FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY APPLICATION (2016-2028)
TABLE 027. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY COUNTRY (2016-2028)
TABLE 028. SYNEOS HEALTH: SNAPSHOT
TABLE 029. SYNEOS HEALTH: BUSINESS PERFORMANCE
TABLE 030. SYNEOS HEALTH: PRODUCT PORTFOLIO
TABLE 031. SYNEOS HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 031. PAREXEL: SNAPSHOT
TABLE 032. PAREXEL: BUSINESS PERFORMANCE
TABLE 033. PAREXEL: PRODUCT PORTFOLIO
TABLE 034. PAREXEL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 034. PREMIER RESEARCH: SNAPSHOT
TABLE 035. PREMIER RESEARCH: BUSINESS PERFORMANCE
TABLE 036. PREMIER RESEARCH: PRODUCT PORTFOLIO
TABLE 037. PREMIER RESEARCH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 037. COURANTE ONCOLOGY: SNAPSHOT
TABLE 038. COURANTE ONCOLOGY: BUSINESS PERFORMANCE
TABLE 039. COURANTE ONCOLOGY: PRODUCT PORTFOLIO
TABLE 040. COURANTE ONCOLOGY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 040. CMIC: SNAPSHOT
TABLE 041. CMIC: BUSINESS PERFORMANCE
TABLE 042. CMIC: PRODUCT PORTFOLIO
TABLE 043. CMIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 043. PROMETRIKA: SNAPSHOT
TABLE 044. PROMETRIKA: BUSINESS PERFORMANCE
TABLE 045. PROMETRIKA: PRODUCT PORTFOLIO
TABLE 046. PROMETRIKA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 046. ICON: SNAPSHOT
TABLE 047. ICON: BUSINESS PERFORMANCE
TABLE 048. ICON: PRODUCT PORTFOLIO
TABLE 049. ICON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 049. WUXI APPTEC: SNAPSHOT
TABLE 050. WUXI APPTEC: BUSINESS PERFORMANCE
TABLE 051. WUXI APPTEC: PRODUCT PORTFOLIO
TABLE 052. WUXI APPTEC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 052. IQVIA: SNAPSHOT
TABLE 053. IQVIA: BUSINESS PERFORMANCE
TABLE 054. IQVIA: PRODUCT PORTFOLIO
TABLE 055. IQVIA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 055. PRA: SNAPSHOT
TABLE 056. PRA: BUSINESS PERFORMANCE
TABLE 057. PRA: PRODUCT PORTFOLIO
TABLE 058. PRA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 058. LABCORP: SNAPSHOT
TABLE 059. LABCORP: BUSINESS PERFORMANCE
TABLE 060. LABCORP: PRODUCT PORTFOLIO
TABLE 061. LABCORP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 061. MEDPACE: SNAPSHOT
TABLE 062. MEDPACE: BUSINESS PERFORMANCE
TABLE 063. MEDPACE: PRODUCT PORTFOLIO
TABLE 064. MEDPACE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 064. WORLDWIDE CLINICAL TRIALS: SNAPSHOT
TABLE 065. WORLDWIDE CLINICAL TRIALS: BUSINESS PERFORMANCE
TABLE 066. WORLDWIDE CLINICAL TRIALS: PRODUCT PORTFOLIO
TABLE 067. WORLDWIDE CLINICAL TRIALS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 067. PPD: SNAPSHOT
TABLE 068. PPD: BUSINESS PERFORMANCE
TABLE 069. PPD: PRODUCT PORTFOLIO
TABLE 070. PPD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 070. EPS INTERNATIONAL: SNAPSHOT
TABLE 071. EPS INTERNATIONAL: BUSINESS PERFORMANCE
TABLE 072. EPS INTERNATIONAL: PRODUCT PORTFOLIO
TABLE 073. EPS INTERNATIONAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET COMPETITIVE RIVALRY
TABLE 005. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET THREAT OF NEW ENTRANTS
TABLE 006. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET THREAT OF SUBSTITUTES
TABLE 007. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET BY TYPE
TABLE 008. CLINICAL CRO MARKET OVERVIEW (2016-2028)
TABLE 009. PRECLINICAL CRO MARKET OVERVIEW (2016-2028)
TABLE 010. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET BY APPLICATION
TABLE 011. SMALL MEDIUM ENTERPRISE MARKET OVERVIEW (2016-2028)
TABLE 012. LARGE ENTERPRISE MARKET OVERVIEW (2016-2028)
TABLE 013. NORTH AMERICA FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY TYPE (2016-2028)
TABLE 014. NORTH AMERICA FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY APPLICATION (2016-2028)
TABLE 015. N FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY COUNTRY (2016-2028)
TABLE 016. EUROPE FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY TYPE (2016-2028)
TABLE 017. EUROPE FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY APPLICATION (2016-2028)
TABLE 018. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY COUNTRY (2016-2028)
TABLE 019. ASIA PACIFIC FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY TYPE (2016-2028)
TABLE 020. ASIA PACIFIC FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY APPLICATION (2016-2028)
TABLE 021. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY COUNTRY (2016-2028)
TABLE 022. MIDDLE EAST & AFRICA FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY TYPE (2016-2028)
TABLE 023. MIDDLE EAST & AFRICA FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY APPLICATION (2016-2028)
TABLE 024. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY COUNTRY (2016-2028)
TABLE 025. SOUTH AMERICA FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY TYPE (2016-2028)
TABLE 026. SOUTH AMERICA FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY APPLICATION (2016-2028)
TABLE 027. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET, BY COUNTRY (2016-2028)
TABLE 028. SYNEOS HEALTH: SNAPSHOT
TABLE 029. SYNEOS HEALTH: BUSINESS PERFORMANCE
TABLE 030. SYNEOS HEALTH: PRODUCT PORTFOLIO
TABLE 031. SYNEOS HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 031. PAREXEL: SNAPSHOT
TABLE 032. PAREXEL: BUSINESS PERFORMANCE
TABLE 033. PAREXEL: PRODUCT PORTFOLIO
TABLE 034. PAREXEL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 034. PREMIER RESEARCH: SNAPSHOT
TABLE 035. PREMIER RESEARCH: BUSINESS PERFORMANCE
TABLE 036. PREMIER RESEARCH: PRODUCT PORTFOLIO
TABLE 037. PREMIER RESEARCH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 037. COURANTE ONCOLOGY: SNAPSHOT
TABLE 038. COURANTE ONCOLOGY: BUSINESS PERFORMANCE
TABLE 039. COURANTE ONCOLOGY: PRODUCT PORTFOLIO
TABLE 040. COURANTE ONCOLOGY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 040. CMIC: SNAPSHOT
TABLE 041. CMIC: BUSINESS PERFORMANCE
TABLE 042. CMIC: PRODUCT PORTFOLIO
TABLE 043. CMIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 043. PROMETRIKA: SNAPSHOT
TABLE 044. PROMETRIKA: BUSINESS PERFORMANCE
TABLE 045. PROMETRIKA: PRODUCT PORTFOLIO
TABLE 046. PROMETRIKA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 046. ICON: SNAPSHOT
TABLE 047. ICON: BUSINESS PERFORMANCE
TABLE 048. ICON: PRODUCT PORTFOLIO
TABLE 049. ICON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 049. WUXI APPTEC: SNAPSHOT
TABLE 050. WUXI APPTEC: BUSINESS PERFORMANCE
TABLE 051. WUXI APPTEC: PRODUCT PORTFOLIO
TABLE 052. WUXI APPTEC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 052. IQVIA: SNAPSHOT
TABLE 053. IQVIA: BUSINESS PERFORMANCE
TABLE 054. IQVIA: PRODUCT PORTFOLIO
TABLE 055. IQVIA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 055. PRA: SNAPSHOT
TABLE 056. PRA: BUSINESS PERFORMANCE
TABLE 057. PRA: PRODUCT PORTFOLIO
TABLE 058. PRA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 058. LABCORP: SNAPSHOT
TABLE 059. LABCORP: BUSINESS PERFORMANCE
TABLE 060. LABCORP: PRODUCT PORTFOLIO
TABLE 061. LABCORP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 061. MEDPACE: SNAPSHOT
TABLE 062. MEDPACE: BUSINESS PERFORMANCE
TABLE 063. MEDPACE: PRODUCT PORTFOLIO
TABLE 064. MEDPACE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 064. WORLDWIDE CLINICAL TRIALS: SNAPSHOT
TABLE 065. WORLDWIDE CLINICAL TRIALS: BUSINESS PERFORMANCE
TABLE 066. WORLDWIDE CLINICAL TRIALS: PRODUCT PORTFOLIO
TABLE 067. WORLDWIDE CLINICAL TRIALS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 067. PPD: SNAPSHOT
TABLE 068. PPD: BUSINESS PERFORMANCE
TABLE 069. PPD: PRODUCT PORTFOLIO
TABLE 070. PPD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 070. EPS INTERNATIONAL: SNAPSHOT
TABLE 071. EPS INTERNATIONAL: BUSINESS PERFORMANCE
TABLE 072. EPS INTERNATIONAL: PRODUCT PORTFOLIO
TABLE 073. EPS INTERNATIONAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET OVERVIEW BY TYPE
FIGURE 012. CLINICAL CRO MARKET OVERVIEW (2016-2028)
FIGURE 013. PRECLINICAL CRO MARKET OVERVIEW (2016-2028)
FIGURE 014. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET OVERVIEW BY APPLICATION
FIGURE 015. SMALL MEDIUM ENTERPRISE MARKET OVERVIEW (2016-2028)
FIGURE 016. LARGE ENTERPRISE MARKET OVERVIEW (2016-2028)
FIGURE 017. NORTH AMERICA FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 018. EUROPE FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 019. ASIA PACIFIC FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 020. MIDDLE EAST & AFRICA FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. SOUTH AMERICA FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET OVERVIEW BY TYPE
FIGURE 012. CLINICAL CRO MARKET OVERVIEW (2016-2028)
FIGURE 013. PRECLINICAL CRO MARKET OVERVIEW (2016-2028)
FIGURE 014. FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET OVERVIEW BY APPLICATION
FIGURE 015. SMALL MEDIUM ENTERPRISE MARKET OVERVIEW (2016-2028)
FIGURE 016. LARGE ENTERPRISE MARKET OVERVIEW (2016-2028)
FIGURE 017. NORTH AMERICA FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 018. EUROPE FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 019. ASIA PACIFIC FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 020. MIDDLE EAST & AFRICA FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. SOUTH AMERICA FULL-SERVICE CLINICAL RESEARCH ORGANIZATION (CRO) MARKET OVERVIEW BY COUNTRY (2016-2028)
